Biopharmaceutical companies are under constant pressure to deliver double-digit growth. In traditional markets such as the U.S., Japan, and the European Union growth is stagnant, and profit margins are falling due to increased price pressure from governments. As a result companies are looking to...

Biopharmaceutical companies are focusing on operational efficiency more than ever before due to cost pressures, generic competition, complex pricing, regulations, and globalization. Due to the low probabilities of success of drug development and achieving market penetration, it is critical for a...

There are various reasons why companies manufacture their goods in different areas of the world. These reasons include: lower labor costs, emerging markets, tax and tariff considerations, and intellectual property issues. With the constant pressure to decrease costs, outsourcing is becoming more...